Trialect

Active

NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)

National Institutes of Health

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of support for cancer research career continuity.

Applications are limited to four per institution per receipt date including new (A0), resubmissions (A1) and renewal (T2); NCI-designated cancer center consortia are considered one institution. NCI seeks a broad representation of institutions for this award mechanism and may take this into account when making funding decisions.

Deadlines:

Duke Internal: TBA
Application Due Date(s): Nov. 4, 2024; Nov. 4, 2025

PAR-24-274 Expiration Date November 05, 2025

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Eligible applicants will be clinician scientists who have a clinical degree (M.D., D.O., D.D.S., D.M.D., O.D., D.C., PharmD., N.D., D.V.M.), possess active licensure, and are actively practicing in an oncology clinical setting. Individuals with a Ph.D. or other doctoral degree that have direct contact with patients or healthy subjects in clinical disciplines such as clinical psychology, nursing, clinical genetics, speech-language pathology, audiology, or rehabilitation are also eligible.
At the time of application, the applicant cannot hold as a Principal Investigator current R01, P01, or other significant NIH funding (past funding does not affect eligibility). Support from P50 Career Development awards, R03, R21, P30 funding, or national network funding will be allowed, as long as the total NCI support does not exceed 6 person-months. Future substantial independent NIH funding will require the awardee to forfeit the R50.
The applicant must have a record of involvement in NCI-funded cancer clinical trial-related activities and be engaged in the conduct of NCI-funded cancer clinical trials research at an academic medical center or at a community center that holds an NCORP award (primary site).
At the time of submission, the Research Specialist must have been at the institution for at least the previous two years.
The Research Specialist must have a full-time position at the institution and be more than six years from initial faculty appointment at the time of the application submission deadline (including appointments held at other institutes). The Research Specialist must commit 2.4 to 4.8 person-months to NCI-funded clinical activities described in the Research Plan of the R50 application during the life of the award. The Research Specialist may engage in other duties as part of the remaining 9.6 to 7.2 person-month effort not covered by this award. The maximum funded effort allowed on all NCI grants, including the R50, will be capped at 6 person-months.
The Research Specialist must have demonstrated professional accomplishments consonant with their career status and should have demonstrated cancer clinical research experience relevant to the NCI mission.